+39 02 610346.1 - info@newron.com

Success in CNS drug development – Innovation in Rare Diseases

We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. Our shares are listed on the SIX Swiss Exchange (NWRN).

Latest press releases

  • 13Jun
    Newron provides update on STARS clinical study with sarizotan for the treatment of Rett syndrome

     

  • 29May
    Newron Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference

  • 15May
    Newron Pharmaceuticals to Present at the UBS Global Healthcare Conference 2018

  • 27Mar
    Shareholders accepted all motions at the AGM 2018

     

  • 1Mar
    Newron announces 2017 financial results and provides outlook for 2018

     

  • 13Feb
    Newron Supports Global Rare Disease Day® 2018 and Rett Syndrome Studies

     

View All

Newron share price

Events

  • 4Sep
    H.C. Wainwright Annual Healthcare Conference
    September 4-6, 2018 - The St. Regis  New York Hotel, New York, NY, USA
  • 14Aug
    Wedbush PacGrow Healthcare Conference

    August 14-15, 2018; Parker New York, New York, NY, USA

  • 6Jun
    Vontobel Summer Conference

    June 5-6, 2018 - Victoria-Jungfrau Grand Hotel & Spa, Interlaken, Switzerland

View Event Calendar